30

Xiangxue Pharmaceutical Co LtdSHE 300147 Stock Report

Last reporting period 30 Sep, 2023

Updated 08 Nov, 2024

Last price

Market cap $B

0.628

Micro

Exchange

XSHE - Shenzhen Stock Exchange

300147.SZ Stock Analysis

30

Uncovered

Xiangxue Pharmaceutical Co Ltd is uncovered by Eyestock quantitative analysis.

Rating

To assess the quality of a company's business, we have collected all financial data from the statements and presented them in the form of a single number - the company's rating. Rating value of 100 is the threshold for determining a viable investment.

-25/100

Low score

Market cap $B

0.628

Dividend yield

0.81 %

Shares outstanding

658.72 B

Xiangxue Pharmaceutical Co., Ltd. develops pharmaceutical products, Chinese herbal compound medicine, biomedical engineering product, functional drink, healthy food and herbal planting. The company is headquartered in Guangzhou, Guangdong and currently employs 3,378 full-time employees. The company went IPO on 2010-12-15. is a China-based company principally engaged in the research, development, production and distribution of traditional Chinese medicines and herbal decoction pieces. The firm's main products include antiviral oral liquids, indigowoad root granules, Exocarpium Citri Reticulatae series Chinese patent drugs and herbal decoction pieces, among others. The firm is also involved in the manufacture and sale of medical devices, health products, soft drinks and biological products. The firm distributes its products in domestic market.

View Section: Eyestock Rating